Anticoagulant reversal drugs market size is estimated to grow by USD 877.37 million from 2022 to 2026 at a CAGR of 12% with the hospital pharmacy having largest market share. Increasing prevalence of coagulation disorders will be a key driver fueling the anticoagulant reversal drugs growth during the forecast period.